TScan TherapeuticsTCRX
那斯達克 · USD
0.92
-0.05
(-4.87%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
TScan TherapeuticsTCRX
0.92
-0.05
(-4.87%)
財務數據
損益表
- 0.07
- 0.01
- 0.01
- 0.01
- 0.01
- 0.02
- 0.03
- 0.03
- 0.03
- 0.01
- 85.52
- -92.15
- -5.30
- 95.71
- -36.61
- 226.47
- 41.69
- -18.37
- 2.23
- -61.75
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 982 | 2,567 | 2,511 | 3,076 | 2,171 | 665 | 1,049 | 536 | 566 | 7,211 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 982 | 2,567 | 2,511 | 3,076 | 2,171 | 665 | 1,049 | 536 | - | 7,211 |
營業費用 | 30,121 | 26,425 | 39,563 | 41,729 | 38,421 | 37,377 | 33,671 | 34,650 | - | 28,568 |
研發費用 | 21,904 | 20,039 | 31,689 | 32,634 | 29,788 | 29,354 | 26,262 | 26,877 | 24,857 | 22,406 |
推銷及管理費用 | 8,217 | 6,386 | 7,874 | 9,095 | 8,633 | 8,023 | 7,409 | 7,773 | 7,082 | 6,162 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -29,139 | -23,858 | -37,052 | -38,653 | -36,250 | -36,712 | -32,622 | -34,114 | -31,373 | -21,357 |
其他收入及費用 | 1,162 | 1,583 | 2,041 | 2,390 | 2,802 | 1,687 | 3,693 | 3,405 | 2,190 | 2,596 |
利息費用 | 689 | 702 | 699 | 689 | 679 | 784 | 958 | 952 | 959 | 852 |
稅前純益 | -28,666 | -22,977 | -35,710 | -36,952 | -34,127 | -35,809 | -29,887 | -31,661 | -30,142 | -19,613 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -28,666 | -22,977 | -35,710 | -36,952 | -34,127 | -35,809 | -29,887 | -31,661 | -30,142 | -19,613 |
基本每股稅後盈餘(元) | -0.22 | -0.18 | -0.28 | -0.28 | -0.26 | -0.30 | -0.25 | -0.28 | -0.32 | - |
稀釋每股稅後盈餘(元) | -0.22 | -0.18 | -0.27 | -0.28 | -0.26 | -0.30 | -0.25 | -0.27 | -0.32 | -0.11 |
基本平均股數(千股) | 129913.00 | 129862.00 | 129835.00 | 129730.00 | 129678.00 | 120789.00 | 118700.00 | 113425.00 | 94875.00 | - |
稀釋平均股數(千股) | 129913.00 | 129862.00 | 129835.00 | 129730.00 | 129678.00 | 120789.00 | 118700.00 | 113425.00 | 94875.00 | - |
還原基本每股稅後盈餘(元) | -0.22 | -0.18 | -0.28 | -0.28 | -0.26 | -0.30 | -0.25 | -0.28 | -0.32 | - |
還原稀釋每股稅後盈餘(元) | -0.22 | -0.18 | -0.27 | -0.28 | -0.26 | -0.30 | -0.25 | -0.27 | -0.32 | -0.11 |
還原基本平均股數(千股) | 129,913 | 129,862 | 129,835 | 129,730 | 129,678 | 120,789 | 118,700 | 113,425 | 94,875 | - |
還原稀釋平均股數(千股) | 129,913 | 129,862 | 129,835 | 129,730 | 129,678 | 120,789 | 118,700 | 113,425 | 94,875 | - |
EBITDA(千元) | -27,284 | -21,607 | -34,535 | -36,351 | -34,047 | -35,864 | -29,403 | -29,986 | -28,382 | -18,318 |